BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 048738
(355 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
Length = 269
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 132 LAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 184
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 185 IAAAAFHLALYTVTGQS 201
>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
Length = 268
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 132 LAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 184
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 185 IAAAAFHLALYTVTGQS 201
>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
Length = 262
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 132 LAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 184
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 185 IAAAAFHLALYTVTGQS 201
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 132 LAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 184
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 185 IAAAAFHLALYTVTGQS 201
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 132 LAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 184
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 185 IAAAAFHLALYTVTGQS 201
>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 264
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 132 LAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 184
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 185 IAAAAFHLALYTVTGQS 201
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 132 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 180
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 181 LPSVIAAAAFHLALYTVTGQS 201
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 132 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 180
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 181 LPSVIAAAAFHLALYTVTGQS 201
>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 25 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 72
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 73 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 131
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 132 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 180
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 181 LPSVIAAAAFHLALYTVTGQS 201
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 23 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 70
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 71 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 129
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 130 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 178
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 179 LPSVIAGAAFHLALYTVTGQS 199
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 28 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 75
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 76 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 134
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 135 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 183
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 184 LPSVIAGAAFHLALYTVTGQS 204
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 22 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 69
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 70 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 128
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 129 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 177
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 178 LPSVIAGAAFHLALYTVTGQS 198
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 24 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 71
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 72 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 130
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 131 LTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 183
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 184 IAGAAFHLALYTVTGQS 200
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 19 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 66
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 67 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 125
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 126 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 174
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 175 LPSVIAGAAFHLALYTVTGQS 195
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 21 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 68
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 69 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 127
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 128 LTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 180
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 181 IAGAAFHLALYTVTGQS 197
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 23 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 70
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 71 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 129
Query: 189 LGWRLGCITTYSYVELLLTN-------FDSLEFHLHNELTTLHINQTNADARLLKYQPSV 241
L + L T ++ + +SL L EL+ + +AD LKY PSV
Sbjct: 130 LTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPSV 182
Query: 242 VAVSALWCSLDELTASS 258
+A +A +L +T S
Sbjct: 183 IAGAAFHLALYTVTGQS 199
>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 261
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 69 PEPGYVEYL-DQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTC 127
P+ GY++ D +N++ R + WL++V Y L + +LHL Y+
Sbjct: 24 PKVGYMKRQPDITNSM---RAILVDWLVEVGEEYKLQNETLHLAVN----------YIDR 70
Query: 128 VLSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQ 187
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 71 FLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYSKKQVLRMEHLVLK 129
Query: 188 SLGWRLGCIT-----TYSYVELLLTN--FDSLEFHLHNELTTLHINQTNADARLLKYQPS 240
L + L T T ++ L N +SL L EL+ + +AD LKY PS
Sbjct: 130 VLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPS 182
Query: 241 VVAVSALWCSLDELTASS 258
++A +A +L +T S
Sbjct: 183 LIAGAAFHLALYTVTGQS 200
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 69 PEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTCV 128
P+ GY++ Q + R + WL++V Y L + +LHL Y+
Sbjct: 21 PKVGYMK--KQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVN----------YIDRF 68
Query: 129 LSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQS 188
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 69 LSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYTKKQVLRMEHLVLKV 127
Query: 189 LGWRLGCITTYSYVELLLTNF-----------DSLEFHLHNELTTLHINQTNADARLLKY 237
L + L T V LT + +SL L EL+ + +AD LKY
Sbjct: 128 LTFDLAAPT----VNQFLTQYFLHQQPANCKVESLAMFL-GELSLI-----DADP-YLKY 176
Query: 238 QPSVVAVSALWCSLDELTASS 258
PSV+A +A +L +T S
Sbjct: 177 LPSVIAGAAFHLALYTVTGQS 197
>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 258
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 69 PEPGYVEYL-DQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTC 127
P+ GY++ D +N++ R + WL++V Y L + +LHL Y+
Sbjct: 21 PKVGYMKRQPDITNSM---RAILVDWLVEVGEEYKLQNETLHLAVN----------YIDR 67
Query: 128 VLSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQ 187
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 68 FLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYSKKQVLRMEHLVLK 126
Query: 188 SLGWRLGCIT-----TYSYVELLLTN--FDSLEFHLHNELTTLHINQTNADARLLKYQPS 240
L + L T T ++ L N +SL L EL+ + +AD LKY PS
Sbjct: 127 VLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPS 179
Query: 241 VVAVSALWCSLDELTASS 258
++A +A +L +T S
Sbjct: 180 LIAGAAFHLALYTVTGQS 197
>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 257
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 69 PEPGYVEYL-DQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFPTNRVDIKKSVYVTC 127
P+ GY++ D +N++ R + WL++V Y L + +LHL Y+
Sbjct: 21 PKVGYMKRQPDITNSM---RAILVDWLVEVGEEYKLQNETLHLAVN----------YIDR 67
Query: 128 VLSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQ 187
LS ++LV A + +ASKF + P + E + D ++ + RME +L+
Sbjct: 68 FLSSMSVLRGKLQLVGTAAMLLASKFEEIYPPEVAEF-VYITDDTYSKKQVLRMEHLVLK 126
Query: 188 SLGWRLGCIT-----TYSYVELLLTN--FDSLEFHLHNELTTLHINQTNADARLLKYQPS 240
L + L T T ++ L N +SL L EL+ + +AD LKY PS
Sbjct: 127 VLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFL-GELSLI-----DADP-YLKYLPS 179
Query: 241 VVAVSALWCSLDELTASS 258
++A +A +L +T S
Sbjct: 180 LIAGAAFHLALYTVTGQS 197
>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
Length = 283
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 19/65 (29%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 138 MVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQSLGWRLGCIT 197
+++L+ ++ L IA+K + P LH+ D + I MEL ++++L WRL +T
Sbjct: 92 LLQLIGISSLFIAAKLEEIYPPKLHQFAYVT-DGACSGDEILTMELMIMKALKWRLSPLT 150
Query: 198 TYSYV 202
S++
Sbjct: 151 IVSWL 155
>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
Length = 306
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 42/198 (21%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 67 YMPEPGYVEYLDQSNNLPHFRFRAIQWLIKVPIPYVLISYSLHLLFP--TNRVDIKKSVY 124
Y+P Y + + Q PH R W+++V +FP N +D Y
Sbjct: 52 YVPRASYFQCV-QREIKPHMRKMLAYWMLEV----CEEQRCEEEVFPLAMNYLD----RY 102
Query: 125 VTCVLSPAEWKYWMVELVSVACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELT 184
++CV + + ++L+ C+ +ASK +T+ ++ ++ + D++ +R E+
Sbjct: 103 LSCVPT----RKAQLQLLGAVCMLLASKLRETTPLTIEKLCIYT-DHAVSPRQLRDWEVL 157
Query: 185 LLQSLGWRLGCITTYSYVELLLTNF----DSLEFHLHNELTTLHINQTNADARLLKYQPS 240
+L L W L + + ++ +L D + T L + T D Y PS
Sbjct: 158 VLGKLKWDLAAVIAHDFLAFILHRLSLPRDRQALVKKHAQTFLALCAT--DYTFAMYPPS 215
Query: 241 VVAVSALWCSLDELTASS 258
++A ++ ++ L A S
Sbjct: 216 MIATGSIGAAVQGLGACS 233
>pdb|1G3N|C Chain C, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|G Chain G, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 257
Score = 28.5 bits (62), Expect = 6.5, Method: Compositional matrix adjust.
Identities = 31/110 (28%), Positives = 43/110 (39%), Gaps = 7/110 (6%)
Query: 145 ACLSIASKFNDTSSPSLHEIQMEELDYSFQSSTIRRMELTLLQSLGWRLGCITTYSYVEL 204
ACL +ASK + S + D SF + E LL+ L WR +
Sbjct: 99 ACLLVASKLRSLTPISTSSLCYAAAD-SFSRQELIDQEKELLEKLAWRTEAVLATDVTSF 157
Query: 205 LLTNFDSLEFHL---HNELTTLHINQTNADARLLKYQPSVVAVSALWCSL 251
LL HL H+E+ TL I + D S+ +SA C+L
Sbjct: 158 LLLKLVGGSQHLDFWHHEVNTL-ITKALVDPLTGSLPASI--ISAAGCAL 204
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.134 0.413
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,959,615
Number of Sequences: 62578
Number of extensions: 368522
Number of successful extensions: 576
Number of sequences better than 100.0: 25
Number of HSP's better than 100.0 without gapping: 2
Number of HSP's successfully gapped in prelim test: 23
Number of HSP's that attempted gapping in prelim test: 552
Number of HSP's gapped (non-prelim): 25
length of query: 355
length of database: 14,973,337
effective HSP length: 100
effective length of query: 255
effective length of database: 8,715,537
effective search space: 2222461935
effective search space used: 2222461935
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)